Search
Patexia Research
Case number 2018-1051

Kowa Company, Ltd. v. Amneal Pharmaceuticals, LLC > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 KOWA COMPANY, LTD. v. AMNEAL PHARMACEUTICALS, LLC [RULE 36 JUDGMENT] [nonprecedential] (0)
Jan 16, 2019 68 Mandate issued to the United States District Court for the Southern District of New York. Service as of this date by the Clerk of Court. [578462] [PBC] [Entered: 01/16/2019 10:42 AM] (2)
Dec 21, 2018 67 Bill of Costs for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Corporation. Service: 12/21/2018 by email. Objection to Bill of Costs due on 01/04/2019. [574221] [18-1051] [David Conlin] [Entered: 12/21/2018 03:47 PM] (0)
Dec 10, 2018 66 JUDGMENT filed. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [570410] [PBC] [Entered: 12/10/2018 09:30 AM] (2)
Dec 6, 2018 65 Submitted after ORAL ARGUMENT by Mr. Steven Arthur Maddox for Amneal Pharmaceuticals, LLC and David G. Conlin for Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Corporation. Panel: Judge: Wallach , Judge: Linn , Judge: Hughes. [569945] [JCP] [Entered: 12/06/2018 02:57 PM] (0)
Dec 4, 2018 64 Response to notice of oral argument from the Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Corporation. [569583] [18-1051] [Kathleen Carr] [Entered: 12/04/2018 01:38 PM] (3)
Dec 4, 2018 63 AMENDED Response to notice of oral argument from the Appellant Amneal Pharmaceuticals, LLC. [569525] [18-1051] [Steven Maddox] [Entered: 12/04/2018 10:51 AM] (3)
Dec 3, 2018 62 AMENDED NOTICE OF ORAL ARGUMENT. Panel: 1812H. Case scheduled Dec 06, 2018 12:30 p.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203.. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [569421] [JCP] [Entered: 12/03/2018 04:52 PM] (2)
Nov 27, 2018 61 ORDER filed granting motion to modify the official caption [59] filed by Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. The revised official caption is reflected in the order. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [567769] [JAB] [Entered: 11/27/2018 10:49 AM] (2)
Nov 20, 2018 60 Amended Certificate of Interest for the Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 11/20/2018 by email. [566976] [18-1051] [Kathleen Carr] [Entered: 11/20/2018 08:34 PM] (3)
Nov 20, 2018 59 MOTION of Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. to modify the official caption [Consent: unopposed]. Service: 11/20/2018 by email. [566975] [18-1051] [Kathleen Carr] [Entered: 11/20/2018 08:32 PM] (10)
Nov 13, 2018 58 Response to oral argument order from the Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd..[564654] [18-1051] [David Conlin] [Entered: 11/13/2018 06:31 PM] (3)
Oct 24, 2018 57 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [13], ERROR: The firm information contained in the entry of appearance for Kathleen Carr does not match the information in the attorney's user account. CORRECTION: Please update as needed to ensure the information with the PACER Service Center matches the entry of appearance. [560076] [JAB] [Entered: 10/24/2018 03:04 PM] (0)
Oct 22, 2018 56 Response to oral argument order from the Appellant Amneal Pharmaceuticals, LLC. [18-1051] [Steven Maddox] [Entered: 10/22/2018 02:45 PM] (2)
Oct 22, 2018 55 NOTICE OF ORAL ARGUMENT. Panel: 1812H. Case scheduled Dec 05, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 11/15/2018. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [559113] [JAB] [Entered: 10/22/2018 01:01 PM] (2)
Jul 2, 2018 54 Notice from Appellant Amneal Pharmaceuticals, LLC regarding conflicts with oral argument (no conflict). Service: 07/02/2018 by email. [533211] [18-1051] [Steven Maddox] [Entered: 07/02/2018 04:28 PM] (2)
Jun 27, 2018 53 6 paper copies of the Joint Appendix Brief (Vol. I - IV) [51] received from Appellant Amneal Pharmaceuticals, LLC. [532208] [CJF] [Entered: 06/27/2018 10:15 AM] (0)
Jun 22, 2018 52 Notice from Appellees Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. regarding conflicts with oral argument (July 9-13, 2018; August 9-10, 2018 and September 4-7, 2018). Service: 06/22/2018 by email. [531521] [18-1051] [Kathleen Carr] [Entered: 06/22/2018 04:34 PM] (2)
Jun 15, 2018 51 APPENDIX FILED (4 vols.) for Amneal Pharmaceuticals, LLC [49]. Number of Pages: 2131. Service: 06/15/2018 by email. The paper copies of the brief should be received by the court on or before 06/28/2018. [531107] [SJ] [Entered: 06/21/2018 09:54 AM] (2143)
Jun 15, 2018 50 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Amneal Pharmaceuticals, LLC and Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 06/15/2018 by email. [530065] [18-1051] [Steven Maddox] [Entered: 06/15/2018 09:56 PM] (4)
Jun 15, 2018 49 TENDERED from Appellant Amneal Pharmaceuticals, LLC and Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Title: JOINT APPENDIX. Service: 06/15/2018 by email. [530064] [18-1051] [Steven Maddox] [Entered: 06/15/2018 09:55 PM] (2143)
Jun 12, 2018 48 6 paper copies of the Reply Brief [47] received from Appellant Amneal Pharmaceuticals, LLC. [528795] [CJF] [Entered: 06/12/2018 01:45 PM] (0)
Jun 8, 2018 47 REPLY BRIEF FILED for Appellant Amneal Pharmaceuticals, LLC [46]. Number of Pages: 29. Service: 06/08/2018 by email. The paper copies of the brief should be received by the court on or before 06/18/2018. Appendix is due 06/15/2018. [528438] [CFT] [Entered: 06/11/2018 02:21 PM] (39)
Jun 8, 2018 46 TENDERED from Appellant Amneal Pharmaceuticals, LLC. Title: REPLY BRIEF. Service: 06/08/2018 by email. [528090] [18-1051] [Steven Maddox] [Entered: 06/08/2018 03:27 PM] (39)
Jun 8, 2018 45 Amended Certificate of Interest for the Appellant Amneal Pharmaceuticals, LLC. Service: 06/08/2018 by email. [528015] [18-1051] [Steven Maddox] [Entered: 06/08/2018 01:47 PM] (3)
May 16, 2018 44 6 paper copies of the Opening Response Brief [41] received from Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. [522239] [CJF] [Entered: 05/16/2018 02:21 PM] (0)
May 15, 2018 43 **TEXT ONLY** ORDER granting motion to extend time to file brief [42] filed by Appellant Amneal Pharmaceuticals, LLC. Reply brief is due 06/08/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [521783] [CMP] [Entered: 05/15/2018 02:04 PM] (0)
May 14, 2018 42 MOTION of Appellant Amneal Pharmaceuticals, LLC to extend the time to 06/08/2018 to file the Reply Brief. [Consent: unopposed]. Service: 05/14/2018 by email. [521546] [18-1051] [Steven Maddox] [Entered: 05/14/2018 04:47 PM] (6)
May 11, 2018 41 BRIEF FILED for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. [40]. Number of Pages: 68. Service: 05/11/2018 by email. The paper copies of the brief should be received by the court on or before 05/21/2018. Appellant Amneal Pharmaceuticals, LLC reply brief is due 05/25/2018. [521323] [CMP] [Entered: 05/14/2018 10:45 AM] (86)
May 11, 2018 40 TENDERED from Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Title: RESPONSE BRIEF. Service: 05/11/2018 by email. [521232] [18-1051] [Kathleen Carr] [Entered: 05/11/2018 08:33 PM] (86)
May 10, 2018 39 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Joseph Rutkowski (entry of appearance [35]) and Jennifer L. Dereka (entry of appearance [36]) are not registered CM/ECF filers with the Federal Circuit.. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [520566] [CMP] [Entered: 05/10/2018 08:39 AM] (0)
May 9, 2018 35 Entry of appearance for Joseph D. Rutkowski as of counsel for Appellees Nissan Chemical Industries, Ltd., Kowa Pharmaceuticals America, Inc. and Kowa Company, Ltd.. Service: 05/09/2018 by email. [520518] [18-1051] [Kathleen Carr] [Entered: 05/09/2018 05:20 PM] (2)
May 9, 2018 34 Entry of appearance for John A. Bauer as of counsel for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 05/09/2018 by email. [520517] [18-1051] [Kathleen Carr] [Entered: 05/09/2018 05:19 PM] (2)
May 9, 2018 36 Entry of appearance for Jennifer L. Dereka as of counsel for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 05/09/2018 by email. [520519] [18-1051] [Kathleen Carr] [Entered: 05/09/2018 05:21 PM] (2)
May 9, 2018 37 Entry of appearance for Peter J. Cuomo as of counsel for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 05/09/2018 by email. [520520] [18-1051] [Kathleen Carr] [Entered: 05/09/2018 05:22 PM] (2)
May 9, 2018 38 Entry of appearance for Thomas H. Wintner as of counsel for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 05/09/2018 by email. [520521] [18-1051] [Kathleen Carr] [Entered: 05/09/2018 05:23 PM] (2)
Apr 12, 2018 33 **TEXT ONLY** ORDER granting motion to extend time to file brief [32] filed by Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. Brief due 05/11/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [512926] [CFT] [Entered: 04/12/2018 03:06 PM] (0)
Apr 12, 2018 32 MOTION of Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. to extend the time to 05/11/2018 to file the Response Brief.. Any response is due within 10 days of service. [Consent: unopposed]. Service: 04/12/2018 by email. [512818] [18-1051] [Kathleen Carr] [Entered: 04/12/2018 11:02 AM] (10)
Feb 14, 2018 31 6 paper copies of the Corrected Opening Brief [30] received from Appellant Amneal Pharmaceuticals, LLC. [497639] [JCP] [Entered: 02/14/2018 12:48 PM] (0)
Feb 12, 2018 30 CORRECTED BRIEF FILED for Appellant Amneal Pharmaceuticals, LLC [29]. Number of Pages: 59. Service: 02/12/2018 by email. The paper copies of the brief should be received by the court on or before 02/21/2018. Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. brief is due 04/20/2018. [497340] [CMP] [Entered: 02/13/2018 12:11 PM] (228)
Feb 12, 2018 29 TENDERED from Appellant Amneal Pharmaceuticals, LLC. Title: CORRECTED OPENING BRIEF. Service: 02/12/2018 by email. [497153] [Steven Maddox] [Entered: 02/12/2018 04:47 PM] (228)
Feb 9, 2018 28 **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [24] filed by Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. brief is due 04/20/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [496827] [CMP] [Entered: 02/09/2018 04:34 PM] (0)
Feb 9, 2018 27 NOTICE OF REJECTION: The brief of Appellant Amneal Pharmaceuticals, LLC, Brief of Appellant [25], is not in compliance with the rules of this court and is therefore rejected for filing. Corrected Brief is due 02/23/2018. Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. brief is due 03/21/2018. Service as of this date by Clerk of Court. [496814] [CMP] [Entered: 02/09/2018 04:23 PM] (2)
Feb 9, 2018 26 Official caption revised to reflect terminated parties Apotex, Inc. and Apotex Corp. due to voluntary dismissal of consolidated case 18-1052. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [496775] [CMP] [Entered: 02/09/2018 03:26 PM] (0)
Feb 9, 2018 25 TENDERED from Appellant Amneal Pharmaceuticals, LLC. Title: OPENING BRIEF. Service: 02/09/2018 by email. [496747] This brief has been rejected. See Doc No. [27]. [Steven Maddox] [Entered: 02/09/2018 02:43 PM] (0)
Feb 8, 2018 24 MOTION of Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. to extend the time to 04/20/2018 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/08/2018 by email. [496528] [Kathleen Carr] [Entered: 02/08/2018 08:30 PM] (9)
Dec 1, 2017 23 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [479578] [CMP] [Entered: 12/01/2017 11:50 AM] (0)
Nov 15, 2017 22 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The certificate of interest included with Appellant's motion to extend time [20] is incomplete as to updated form 9, question #5. CORRECTION: Please ensure future filings comply with recently amended FCR 47.4 and 47.5. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [475744] [CMP] [Entered: 11/15/2017 12:17 PM] (0)
Nov 15, 2017 21 **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [20] filed by Appellants Apotex Corp., Apotex, Inc. and Amneal Pharmaceuticals, LLC. Brief is due 02/09/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [475740] [CMP] [Entered: 11/15/2017 12:15 PM] (0)
Nov 14, 2017 20 MOTION of Appellants Amneal Pharmaceuticals, LLC, Apotex Corp. and Apotex, Inc. to extend the time to 02/09/2018 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 11/14/2017 by email. [475490] [Steven Maddox] [Entered: 11/14/2017 04:24 PM] (9)
Oct 31, 2017 19 Corrected Certificate of Interest for the Appellants Apotex Corp. and Apotex, Inc.. Service: 10/31/2017 by email. [471907] [Steven Maddox] [Entered: 10/31/2017 12:48 PM] (3)
Oct 31, 2017 18 Corrected Certificate of Interest for the Appellant Amneal Pharmaceuticals, LLC. Service: 10/31/2017 by email. [471906] [Steven Maddox] [Entered: 10/31/2017 12:47 PM] (3)
Oct 31, 2017 17 NOTICE OF DEFICIENCY: The certificates of interest [5] and [11] filed by Appellants Amneal Pharmaceuticals, LLC, Apotex Corp., and Apotex, Inc. in 18-1051 are incomplete [see question 5] and therefore cannot be accepted for filing at this time. Question 5 may not be left blank; if applicable, "none" may be used. You are being afforded the opportunity to correct the deficiency. [471883] [CMP] [Entered: 10/31/2017 12:01 PM] (0)
Oct 30, 2017 16 Docketing Statement for the Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 10/30/2017 by email. [471613] [Kathleen Carr] [Entered: 10/30/2017 06:15 PM] (4)
Oct 30, 2017 15 Certificate of Interest for the Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 10/30/2017 by email. [471612] [Kathleen Carr] [Entered: 10/30/2017 06:13 PM] (3)
Oct 30, 2017 14 Entry of appearance for Adam P. Samansky as of counsel for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 10/30/2017 by email. [471609] [Kathleen Carr] [Entered: 10/30/2017 06:12 PM] (2)
Oct 30, 2017 13 Entry of appearance for Kathleen B. Carr as of counsel for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 10/30/2017 by email. [471607] [Kathleen Carr] [Entered: 10/30/2017 06:10 PM] (2)
Oct 30, 2017 12 Entry of appearance for David G. Conlin as principal counsel for Appellees Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.. Service: 10/30/2017 by email. [471605] [Kathleen Carr] [Entered: 10/30/2017 06:08 PM] (2)
Oct 30, 2017 11 Certificate of Interest for the Appellants Apotex Corp. and Apotex, Inc.. Service: 10/30/2017 by email. [471494] [Steven Maddox] [Entered: 10/30/2017 04:07 PM] (0)
Oct 30, 2017 10 Docketing Statement for the Appellants Apotex Corp. and Apotex, Inc.. Service: 10/30/2017 by email. [471492] [Steven Maddox] [Entered: 10/30/2017 04:06 PM] (6)
Oct 30, 2017 9 Entry of appearance for Kaveh Saba as of counsel for Appellants Amneal Pharmaceuticals, LLC, Apotex Corp. and Apotex, Inc.. Service: 10/30/2017 by email. [471490] [Steven Maddox] [Entered: 10/30/2017 04:05 PM] (2)
Oct 30, 2017 8 Entry of appearance for Matthew C. Ruedy as of counsel for Appellants Amneal Pharmaceuticals, LLC, Apotex Corp. and Apotex, Inc.. Service: 10/30/2017 by email. [471486] [Steven Maddox] [Entered: 10/30/2017 04:05 PM] (2)
Oct 30, 2017 7 Entry of appearance for Jeremy J. Edwards as of counsel for Appellants Amneal Pharmaceuticals, LLC, Apotex Corp. and Apotex, Inc.. Service: 10/30/2017 by email. [471484] [Steven Maddox] [Entered: 10/30/2017 04:04 PM] (2)
Oct 30, 2017 6 Entry of appearance for Steven A. Maddox as principal counsel for Appellants Amneal Pharmaceuticals, LLC, Apotex Corp. and Apotex, Inc.. Service: 10/30/2017 by email. [471483] [Steven Maddox] [Entered: 10/30/2017 04:03 PM] (2)
Oct 30, 2017 5 Certificate of Interest for the Appellant Amneal Pharmaceuticals, LLC. Service: 10/30/2017 by email. [471459] [Steven Maddox] [Entered: 10/30/2017 03:43 PM] (0)
Oct 30, 2017 4 Docketing Statement for the Appellant Amneal Pharmaceuticals, LLC. Service: 10/30/2017 by email. [471454] [Steven Maddox] [Entered: 10/30/2017 03:42 PM] (6)
Oct 25, 2017 3 Note to file: The following cases are associated: 18-1051 Lead with 18-1052 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [470454] [18-1051, 18-1052] [JCA] [Entered: 10/25/2017 12:26 PM] (0)
Oct 25, 2017 2 ORDER consolidating appeals (18-1051, 18-1052) and modifying the official caption in 18-1051. The revised official caption is reflected in the order. The appellants opening brief is due no later than December 15, 2017. Service as of this date by Clerk of Court. [470450] [18-1051, 18-1052] [JCA] [Entered: 10/25/2017 12:25 PM] (2)
Oct 16, 2017 1 Appeal docketed. Received: 10/12/2017. [467884]Entry of Appearance due 10/30/2017. Certificate of Interest is due on 10/30/2017. Docketing Statement due 10/30/2017. Appellant/Petitioner's brief is due 12/15/2017. [CMP] [Entered: 10/16/2017 09:45 AM] (33)
Menu